NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q1 2025 vs. Q4 2024
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 11 | 10 | −1 |
| Shares | 1.32M | 1.31M | −13.5K (−1.0%) |
| Value | $18.8M | $12.3M | −$6.43M (−34.3%) |
New holders (0)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (1)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HRT Financial LP | 13,655 | $191.0K |